Position锛�Home > health > Content

The World Health Organization reiterates that the monkeypox

Date锛�2025-03-04 22:17Editer锛歛dminRead锛�锛�

On February 27th local time, World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus announced that after the third meeting of the Emergency Committee of the International Health Regulations (2005), the continued outbreak of monkeypox still meets the criteria for a Public Health Emergency of International Concern (PHEIC). This is the third time since the organization first announced monkeypox as constituting PHEIC in August 2024 that the highest level alert has been extended, highlighting the complexity of the global epidemic situation and the urgency of prevention and control.
Global pandemic continues to spread, new variants raise concerns
According to the latest data from WHO, as of February 23, 2025, monkeypox has reported a total of 127905 confirmed cases and 283 deaths in over 100 countries and regions worldwide. The notable feature of this epidemic is the emergence and rapid spread of the monkeypox virus Ib variant. This variant was first discovered in the Democratic Republic of Congo in 2024 and is mainly transmitted through sexual contact. Its transmission ability is stronger than traditional strains and has spread to neighboring countries and Europe and America. In January 2025, the Chinese Center for Disease Control and Prevention announced that a cluster outbreak caused by the Ib variant had been discovered for the first time in China. The source of infection was a foreigner with a history of residing in the Democratic Republic of Congo, and multiple related cases were subsequently reported through close contact.
International community launches collaborative response mechanism
To contain the spread of the epidemic, the WHO Emergency Committee recommends strengthening global monitoring, vaccine distribution, and public education. Tedros Adhanom Ghebreyesus stated that the cross-border transmission risk of monkeypox virus and the potential threat of mutant strains require countries to take "coordinated international action". At present, two monkeypox vaccines have been approved through the WHO Emergency Use List program, and low-income countries can accelerate access to the vaccines. In addition, WHO  We are coordinating donations with vaccine manufacturers and planning to allocate $15 million to support monitoring and prevention activities. Experts call for vigilance against recurring epidemics and inequality
The chairman of the committee, Dimi Ogoina, pointed out that monkeypox caused a global pandemic in 2022 due to neglect in Africa, and it is necessary to avoid a repeat of history. He emphasized that the international community should prioritize providing vaccines and technical support to African countries to prevent the epidemic from further worsening due to uneven resource allocation. Experts from the Chinese Center for Disease Control and Prevention remind that monkeypox is a self limiting disease, but attention should be paid to the severe risk of high-risk populations. The public should avoid contact with suspicious animals and infected individuals, and seek medical attention promptly if symptoms appear.
As the monkeypox epidemic continues to evolve, the international community is facing a dual test of virus mutation and the effectiveness of prevention and control measures. WHO  It is stated that temporary recommendations will be adjusted based on the development of the epidemic, and countries need to remain highly vigilant and respond to this public health challenge through scientific strategies and global cooperation.